Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas
To report the efficacy and complications of diode laser cyclophotocoagulation (cyclodiode) in the management of refractory pediatric glaucomas. Noncomparative interventional case series. Pediatric patients with uncontrolled glaucoma. Seventy-seven eyes of 61 patients underwent cyclodiode. Mean age w...
Gespeichert in:
| Veröffentlicht in: | Ophthalmology (Rochester, Minn.) Minn.), 2002, Vol.109 (2), p.316-323 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 323 |
|---|---|
| container_issue | 2 |
| container_start_page | 316 |
| container_title | Ophthalmology (Rochester, Minn.) |
| container_volume | 109 |
| creator | Kirwan, James F Shah, Peter Khaw, Peng T |
| description | To report the efficacy and complications of diode laser cyclophotocoagulation (cyclodiode) in the management of refractory pediatric glaucomas.
Noncomparative interventional case series.
Pediatric patients with uncontrolled glaucoma. Seventy-seven eyes of 61 patients underwent cyclodiode. Mean age was 7.4 years (range, 0.4–17 years).
Intraocular pressure (IOP), visual acuity, complications.
Diagnoses included aphakic glaucoma, congenital glaucoma, juvenile chronic arthritis, aniridia, anterior segment dysgenesis, and Sturge-Weber syndrome. Sixty percent of eyes were aphakic, and 64% had undergone at least one previous surgical procedure for glaucoma. Patients underwent a mean of 2.3 treatment sessions per eye (maximum, 8 sessions). Mean pretreatment IOP was 32.0 mmHg. After one treatment session, 62% had a clinically useful reduction in IOP ( |
| doi_str_mv | 10.1016/S0161-6420(01)00898-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71430665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161642001008983</els_id><sourcerecordid>71430665</sourcerecordid><originalsourceid>FETCH-LOGICAL-e388t-71d41250a8ee33d91c8cd0377339c3d36061e48a3bc71e70b6ed6dcf053af07d3</originalsourceid><addsrcrecordid>eNpF0cFu1DAQBmALgehSeASQLyA4BGZ2EsfLBaECBakSB-DEwfLak62REy-2U2nfnrRd2svM5dNI__xCPEd4i4Dq3Y9lYKPaNbwGfAOgN7qhB2KFXbtp2h7poVjdkRPxpJQ_AKAUtY_FCaJedxrVSvz-FJJnGW3hLN3BxbS_TDW5ZHdztDWk6b3MKbIMk6yXLEc72R2PPFWZBpl5yNbVlA9yzz7YmoOTu2hnl0ZbnopHg42Fnx33qfj15fPPs6_Nxffzb2cfLxomrWvTo29x3YHVzER-g047D9T3RBtHnhQo5FZb2roeuYetYq-8G6AjO0Dv6VS8ur27z-nvzKWaMRTHMdqJ01xMjy0tybsFvjjCeTuyN_scRpsP5v87FvDyCGxxNi7hJhfKvaO2a7WCxX24dbzEugqcTXGBJ7f8ILOrxqdgEMx1UeamKHPdggE0N0UZon8inYSb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71430665</pqid></control><display><type>article</type><title>Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kirwan, James F ; Shah, Peter ; Khaw, Peng T</creator><creatorcontrib>Kirwan, James F ; Shah, Peter ; Khaw, Peng T</creatorcontrib><description>To report the efficacy and complications of diode laser cyclophotocoagulation (cyclodiode) in the management of refractory pediatric glaucomas.
Noncomparative interventional case series.
Pediatric patients with uncontrolled glaucoma. Seventy-seven eyes of 61 patients underwent cyclodiode. Mean age was 7.4 years (range, 0.4–17 years).
Intraocular pressure (IOP), visual acuity, complications.
Diagnoses included aphakic glaucoma, congenital glaucoma, juvenile chronic arthritis, aniridia, anterior segment dysgenesis, and Sturge-Weber syndrome. Sixty percent of eyes were aphakic, and 64% had undergone at least one previous surgical procedure for glaucoma. Patients underwent a mean of 2.3 treatment sessions per eye (maximum, 8 sessions). Mean pretreatment IOP was 32.0 mmHg. After one treatment session, 62% had a clinically useful reduction in IOP (<22 mmHg or by 30%), but this had fallen to 37% by 12 months. With repeat cyclodiode, 72% had a clinically useful reduction in IOP for a year or more (mean, 8.4-month interval between treatments). Aphakic eyes had a more sustained IOP reduction (
P < 0.01 log rank test). Of treatment failures, 13% had no useful IOP response, and three eyes developed subsequent retinal detachment and loss of vision. No other eyes lost vision because of cyclodiode-related complications. In 5.5% of the treatment sessions there was a significant posttreatment inflammatory episode. Cyclodiode treatment did not enable a reduction in the number of medications.
With repeated treatment, cyclodiode can provide effective control of IOP. However, the success rate is lower than with adults, and younger eyes may recover from treatment more rapidly. Although response may be temporary, cyclodiode has a lower rate of severe adverse effects than surgical modalities and has roles as a temporizing measure, as an adjunct to surgery, or in managing selected patients in whom surgery is undesirable because of a high risk of surgical complications.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/S0161-6420(01)00898-3</identifier><identifier>PMID: 11825816</identifier><identifier>CODEN: OPHTDG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Age Distribution ; Age Factors ; Aphakia, Postcataract - complications ; Biological and medical sciences ; Child ; Child, Preschool ; Ciliary Body - surgery ; Cohort Studies ; Glaucoma - surgery ; Humans ; Infant ; Intraocular Pressure ; Laser Coagulation ; Medical sciences ; Postoperative Complications ; Reoperation ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the eye and orbit ; Treatment Outcome ; Visual Acuity</subject><ispartof>Ophthalmology (Rochester, Minn.), 2002, Vol.109 (2), p.316-323</ispartof><rights>2002 American Academy of Ophthalmology, Inc.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161642001008983$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13454860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11825816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirwan, James F</creatorcontrib><creatorcontrib>Shah, Peter</creatorcontrib><creatorcontrib>Khaw, Peng T</creatorcontrib><title>Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>To report the efficacy and complications of diode laser cyclophotocoagulation (cyclodiode) in the management of refractory pediatric glaucomas.
Noncomparative interventional case series.
Pediatric patients with uncontrolled glaucoma. Seventy-seven eyes of 61 patients underwent cyclodiode. Mean age was 7.4 years (range, 0.4–17 years).
Intraocular pressure (IOP), visual acuity, complications.
Diagnoses included aphakic glaucoma, congenital glaucoma, juvenile chronic arthritis, aniridia, anterior segment dysgenesis, and Sturge-Weber syndrome. Sixty percent of eyes were aphakic, and 64% had undergone at least one previous surgical procedure for glaucoma. Patients underwent a mean of 2.3 treatment sessions per eye (maximum, 8 sessions). Mean pretreatment IOP was 32.0 mmHg. After one treatment session, 62% had a clinically useful reduction in IOP (<22 mmHg or by 30%), but this had fallen to 37% by 12 months. With repeat cyclodiode, 72% had a clinically useful reduction in IOP for a year or more (mean, 8.4-month interval between treatments). Aphakic eyes had a more sustained IOP reduction (
P < 0.01 log rank test). Of treatment failures, 13% had no useful IOP response, and three eyes developed subsequent retinal detachment and loss of vision. No other eyes lost vision because of cyclodiode-related complications. In 5.5% of the treatment sessions there was a significant posttreatment inflammatory episode. Cyclodiode treatment did not enable a reduction in the number of medications.
With repeated treatment, cyclodiode can provide effective control of IOP. However, the success rate is lower than with adults, and younger eyes may recover from treatment more rapidly. Although response may be temporary, cyclodiode has a lower rate of severe adverse effects than surgical modalities and has roles as a temporizing measure, as an adjunct to surgery, or in managing selected patients in whom surgery is undesirable because of a high risk of surgical complications.</description><subject>Adolescent</subject><subject>Age Distribution</subject><subject>Age Factors</subject><subject>Aphakia, Postcataract - complications</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Ciliary Body - surgery</subject><subject>Cohort Studies</subject><subject>Glaucoma - surgery</subject><subject>Humans</subject><subject>Infant</subject><subject>Intraocular Pressure</subject><subject>Laser Coagulation</subject><subject>Medical sciences</subject><subject>Postoperative Complications</subject><subject>Reoperation</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the eye and orbit</subject><subject>Treatment Outcome</subject><subject>Visual Acuity</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0cFu1DAQBmALgehSeASQLyA4BGZ2EsfLBaECBakSB-DEwfLak62REy-2U2nfnrRd2svM5dNI__xCPEd4i4Dq3Y9lYKPaNbwGfAOgN7qhB2KFXbtp2h7poVjdkRPxpJQ_AKAUtY_FCaJedxrVSvz-FJJnGW3hLN3BxbS_TDW5ZHdztDWk6b3MKbIMk6yXLEc72R2PPFWZBpl5yNbVlA9yzz7YmoOTu2hnl0ZbnopHg42Fnx33qfj15fPPs6_Nxffzb2cfLxomrWvTo29x3YHVzER-g047D9T3RBtHnhQo5FZb2roeuYetYq-8G6AjO0Dv6VS8ur27z-nvzKWaMRTHMdqJ01xMjy0tybsFvjjCeTuyN_scRpsP5v87FvDyCGxxNi7hJhfKvaO2a7WCxX24dbzEugqcTXGBJ7f8ILOrxqdgEMx1UeamKHPdggE0N0UZon8inYSb</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Kirwan, James F</creator><creator>Shah, Peter</creator><creator>Khaw, Peng T</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas</title><author>Kirwan, James F ; Shah, Peter ; Khaw, Peng T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e388t-71d41250a8ee33d91c8cd0377339c3d36061e48a3bc71e70b6ed6dcf053af07d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Age Distribution</topic><topic>Age Factors</topic><topic>Aphakia, Postcataract - complications</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Ciliary Body - surgery</topic><topic>Cohort Studies</topic><topic>Glaucoma - surgery</topic><topic>Humans</topic><topic>Infant</topic><topic>Intraocular Pressure</topic><topic>Laser Coagulation</topic><topic>Medical sciences</topic><topic>Postoperative Complications</topic><topic>Reoperation</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the eye and orbit</topic><topic>Treatment Outcome</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirwan, James F</creatorcontrib><creatorcontrib>Shah, Peter</creatorcontrib><creatorcontrib>Khaw, Peng T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirwan, James F</au><au>Shah, Peter</au><au>Khaw, Peng T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2002</date><risdate>2002</risdate><volume>109</volume><issue>2</issue><spage>316</spage><epage>323</epage><pages>316-323</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><coden>OPHTDG</coden><abstract>To report the efficacy and complications of diode laser cyclophotocoagulation (cyclodiode) in the management of refractory pediatric glaucomas.
Noncomparative interventional case series.
Pediatric patients with uncontrolled glaucoma. Seventy-seven eyes of 61 patients underwent cyclodiode. Mean age was 7.4 years (range, 0.4–17 years).
Intraocular pressure (IOP), visual acuity, complications.
Diagnoses included aphakic glaucoma, congenital glaucoma, juvenile chronic arthritis, aniridia, anterior segment dysgenesis, and Sturge-Weber syndrome. Sixty percent of eyes were aphakic, and 64% had undergone at least one previous surgical procedure for glaucoma. Patients underwent a mean of 2.3 treatment sessions per eye (maximum, 8 sessions). Mean pretreatment IOP was 32.0 mmHg. After one treatment session, 62% had a clinically useful reduction in IOP (<22 mmHg or by 30%), but this had fallen to 37% by 12 months. With repeat cyclodiode, 72% had a clinically useful reduction in IOP for a year or more (mean, 8.4-month interval between treatments). Aphakic eyes had a more sustained IOP reduction (
P < 0.01 log rank test). Of treatment failures, 13% had no useful IOP response, and three eyes developed subsequent retinal detachment and loss of vision. No other eyes lost vision because of cyclodiode-related complications. In 5.5% of the treatment sessions there was a significant posttreatment inflammatory episode. Cyclodiode treatment did not enable a reduction in the number of medications.
With repeated treatment, cyclodiode can provide effective control of IOP. However, the success rate is lower than with adults, and younger eyes may recover from treatment more rapidly. Although response may be temporary, cyclodiode has a lower rate of severe adverse effects than surgical modalities and has roles as a temporizing measure, as an adjunct to surgery, or in managing selected patients in whom surgery is undesirable because of a high risk of surgical complications.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11825816</pmid><doi>10.1016/S0161-6420(01)00898-3</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0161-6420 |
| ispartof | Ophthalmology (Rochester, Minn.), 2002, Vol.109 (2), p.316-323 |
| issn | 0161-6420 1549-4713 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71430665 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adolescent Age Distribution Age Factors Aphakia, Postcataract - complications Biological and medical sciences Child Child, Preschool Ciliary Body - surgery Cohort Studies Glaucoma - surgery Humans Infant Intraocular Pressure Laser Coagulation Medical sciences Postoperative Complications Reoperation Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the eye and orbit Treatment Outcome Visual Acuity |
| title | Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T22%3A09%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diode%20laser%20cyclophotocoagulation:%20role%20in%20the%20management%20of%20refractory%20pediatric%20glaucomas&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Kirwan,%20James%20F&rft.date=2002&rft.volume=109&rft.issue=2&rft.spage=316&rft.epage=323&rft.pages=316-323&rft.issn=0161-6420&rft.eissn=1549-4713&rft.coden=OPHTDG&rft_id=info:doi/10.1016/S0161-6420(01)00898-3&rft_dat=%3Cproquest_pubme%3E71430665%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71430665&rft_id=info:pmid/11825816&rft_els_id=S0161642001008983&rfr_iscdi=true |